Arena Investors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,525
Closed -$105K 149
2022
Q3
$105K Hold
10,525
0.05% 95
2022
Q2
$104K Hold
10,525
0.05% 93
2022
Q1
$103K Buy
+10,525
New +$103K 0.07% 78

Arena Investors's LUXA Position: Q4 2022 in Review

Arena Investors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 10,525 shares — an estimated $105K sold.

Arena Investors first reported a position in LUXA in Q1 2022 and held it in 3 quarters. The position peaked at $105K in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Arena Investors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Arena Investors sold 10,525 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $105K.
  • Arena Investors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Arena Investors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $105K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Arena Investors's 13F filing for Q4 2022, filed 14 Feb 2023.